As Johnson & Johnson’s Stelara nears $10 billion in annual sales, the U.S. Big Pharma is going bold with a new DTC campaign for the immunology drug. The "UnstoppaBOLD" campaign “is about patients ...
Johnson & Johnson’s subsidiary Janssen has launched the latest iteration of its “UnstoppaBOLD” campaign for Stelara, an immunosuppressive drug used to treat Crohn’s disease and psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results